SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (842)1/23/2000 11:04:00 PM
From: James J. Ebersberger  Respond to of 1255
 
I bought many thousands of shares at $6.625 and was just wondering what to do with them, now that they are on the way up, but on the OTC.



To: NeuroInvestment who wrote (842)1/23/2000 11:16:00 PM
From: Robert C. Petersen  Read Replies (1) | Respond to of 1255
 
Neuro,
I have been a long-term admirer of your posts.
But with all your projections for the year,
a 4.00 forcast for year-end when stock has
already broken through 4.00 on Friday ?
This is a very conservative call.
Do you wear suspenders and a belt at the same time?
Or was that a typo......curious.....nysebob



To: NeuroInvestment who wrote (842)1/23/2000 11:20:00 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 1255
 
Harry,

Thanks for nice Ampakine review, coming milestone and CORX partnering model.

I am bit pissed on myself after being avoiding OTC bts, while *suspecting* Ampakine potential (CORX case).

If I am not what I am (cheap, what else?) Neuroinvestment L. will be on my desk first of the month.

Thanks again.

Miljenko


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News